Trafficking Defects in Huntington's Disease

Eugenia D Trushina, C. T. McMurray

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Malfunctions of the membrane-trafficking machinery are emerging as defects associated with a number of neurodegenerative diseases, including Huntington's disease (HD). HD is a hereditary and progressive neurodegenerative disorder in which the underlying mutation is a CAG expansion within the coding sequence of the gene. This mutation is referred to as trinucleotide expansion, because the number of CAG triplets present in a mutated gene is greater than the number of CAG triplets found in a normal gene. HD is an autosomal dominant disease; therefore, the expanded CAG repeat is usually present in only one of the two alleles in the cell. Unaffected individuals may have 6 to 25 CAG triplets in both alleles. In HD patients, the disease allele typically contains 36 to 120 CAG triplets. The HD protein called huntingtin (htt) contains a polymorphic glutamine repeat at its N-terminus. As the CAG repeat number grows, the growing polyglutamine tract produces htt with increasingly aberrant properties and leads to selective neuronal death in the striatum. Neurons that are particularly affected in HD are located in the cerebral cortex and the caudate/putamen. Loss of brain cells in these regions causes memory deficits and uncontrolled muscle movements. Once the symptoms begin, death usually occurs within 15 to 20 years. This chapter reviews data that implicate defects in vesicle trafficking as a causative factor leading to toxicity in HD. The chapter specifically focuses on three points: the interactions that implicate htt as a trafficking protein, the way in which trafficking defects arise from the expression of the mutant form of htt (mhtt), and whether defective trafficking is a cause or consequence of toxicity.

Original languageEnglish (US)
Title of host publicationProtein Trafficking in Neurons
PublisherElsevier Inc.
Pages369-389
Number of pages21
ISBN (Print)9780123694379
DOIs
StatePublished - 2007

Fingerprint

Huntington Disease
Defects
Alleles
Neurodegenerative Diseases
Genes
Mutation
Toxicity
Putamen
Memory Disorders
Protein Transport
Glutamine
Cerebral Cortex
Neurodegenerative diseases
Neurons
Muscles
Machinery
Membranes
Muscle
Brain
Proteins

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Trushina, E. D., & McMurray, C. T. (2007). Trafficking Defects in Huntington's Disease. In Protein Trafficking in Neurons (pp. 369-389). Elsevier Inc.. https://doi.org/10.1016/B978-012369437-9/50024-4

Trafficking Defects in Huntington's Disease. / Trushina, Eugenia D; McMurray, C. T.

Protein Trafficking in Neurons. Elsevier Inc., 2007. p. 369-389.

Research output: Chapter in Book/Report/Conference proceedingChapter

Trushina, ED & McMurray, CT 2007, Trafficking Defects in Huntington's Disease. in Protein Trafficking in Neurons. Elsevier Inc., pp. 369-389. https://doi.org/10.1016/B978-012369437-9/50024-4
Trushina ED, McMurray CT. Trafficking Defects in Huntington's Disease. In Protein Trafficking in Neurons. Elsevier Inc. 2007. p. 369-389 https://doi.org/10.1016/B978-012369437-9/50024-4
Trushina, Eugenia D ; McMurray, C. T. / Trafficking Defects in Huntington's Disease. Protein Trafficking in Neurons. Elsevier Inc., 2007. pp. 369-389
@inbook{00a964ba7d22486eb5f7e6dce3fee7bd,
title = "Trafficking Defects in Huntington's Disease",
abstract = "Malfunctions of the membrane-trafficking machinery are emerging as defects associated with a number of neurodegenerative diseases, including Huntington's disease (HD). HD is a hereditary and progressive neurodegenerative disorder in which the underlying mutation is a CAG expansion within the coding sequence of the gene. This mutation is referred to as trinucleotide expansion, because the number of CAG triplets present in a mutated gene is greater than the number of CAG triplets found in a normal gene. HD is an autosomal dominant disease; therefore, the expanded CAG repeat is usually present in only one of the two alleles in the cell. Unaffected individuals may have 6 to 25 CAG triplets in both alleles. In HD patients, the disease allele typically contains 36 to 120 CAG triplets. The HD protein called huntingtin (htt) contains a polymorphic glutamine repeat at its N-terminus. As the CAG repeat number grows, the growing polyglutamine tract produces htt with increasingly aberrant properties and leads to selective neuronal death in the striatum. Neurons that are particularly affected in HD are located in the cerebral cortex and the caudate/putamen. Loss of brain cells in these regions causes memory deficits and uncontrolled muscle movements. Once the symptoms begin, death usually occurs within 15 to 20 years. This chapter reviews data that implicate defects in vesicle trafficking as a causative factor leading to toxicity in HD. The chapter specifically focuses on three points: the interactions that implicate htt as a trafficking protein, the way in which trafficking defects arise from the expression of the mutant form of htt (mhtt), and whether defective trafficking is a cause or consequence of toxicity.",
author = "Trushina, {Eugenia D} and McMurray, {C. T.}",
year = "2007",
doi = "10.1016/B978-012369437-9/50024-4",
language = "English (US)",
isbn = "9780123694379",
pages = "369--389",
booktitle = "Protein Trafficking in Neurons",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Trafficking Defects in Huntington's Disease

AU - Trushina, Eugenia D

AU - McMurray, C. T.

PY - 2007

Y1 - 2007

N2 - Malfunctions of the membrane-trafficking machinery are emerging as defects associated with a number of neurodegenerative diseases, including Huntington's disease (HD). HD is a hereditary and progressive neurodegenerative disorder in which the underlying mutation is a CAG expansion within the coding sequence of the gene. This mutation is referred to as trinucleotide expansion, because the number of CAG triplets present in a mutated gene is greater than the number of CAG triplets found in a normal gene. HD is an autosomal dominant disease; therefore, the expanded CAG repeat is usually present in only one of the two alleles in the cell. Unaffected individuals may have 6 to 25 CAG triplets in both alleles. In HD patients, the disease allele typically contains 36 to 120 CAG triplets. The HD protein called huntingtin (htt) contains a polymorphic glutamine repeat at its N-terminus. As the CAG repeat number grows, the growing polyglutamine tract produces htt with increasingly aberrant properties and leads to selective neuronal death in the striatum. Neurons that are particularly affected in HD are located in the cerebral cortex and the caudate/putamen. Loss of brain cells in these regions causes memory deficits and uncontrolled muscle movements. Once the symptoms begin, death usually occurs within 15 to 20 years. This chapter reviews data that implicate defects in vesicle trafficking as a causative factor leading to toxicity in HD. The chapter specifically focuses on three points: the interactions that implicate htt as a trafficking protein, the way in which trafficking defects arise from the expression of the mutant form of htt (mhtt), and whether defective trafficking is a cause or consequence of toxicity.

AB - Malfunctions of the membrane-trafficking machinery are emerging as defects associated with a number of neurodegenerative diseases, including Huntington's disease (HD). HD is a hereditary and progressive neurodegenerative disorder in which the underlying mutation is a CAG expansion within the coding sequence of the gene. This mutation is referred to as trinucleotide expansion, because the number of CAG triplets present in a mutated gene is greater than the number of CAG triplets found in a normal gene. HD is an autosomal dominant disease; therefore, the expanded CAG repeat is usually present in only one of the two alleles in the cell. Unaffected individuals may have 6 to 25 CAG triplets in both alleles. In HD patients, the disease allele typically contains 36 to 120 CAG triplets. The HD protein called huntingtin (htt) contains a polymorphic glutamine repeat at its N-terminus. As the CAG repeat number grows, the growing polyglutamine tract produces htt with increasingly aberrant properties and leads to selective neuronal death in the striatum. Neurons that are particularly affected in HD are located in the cerebral cortex and the caudate/putamen. Loss of brain cells in these regions causes memory deficits and uncontrolled muscle movements. Once the symptoms begin, death usually occurs within 15 to 20 years. This chapter reviews data that implicate defects in vesicle trafficking as a causative factor leading to toxicity in HD. The chapter specifically focuses on three points: the interactions that implicate htt as a trafficking protein, the way in which trafficking defects arise from the expression of the mutant form of htt (mhtt), and whether defective trafficking is a cause or consequence of toxicity.

UR - http://www.scopus.com/inward/record.url?scp=84882830195&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882830195&partnerID=8YFLogxK

U2 - 10.1016/B978-012369437-9/50024-4

DO - 10.1016/B978-012369437-9/50024-4

M3 - Chapter

AN - SCOPUS:84882830195

SN - 9780123694379

SP - 369

EP - 389

BT - Protein Trafficking in Neurons

PB - Elsevier Inc.

ER -